HomeBUSINESS
BUSINESS

Japan’s 1st Rituxan Biosimilar to Arrive Soon, Sandoz Confident on Market Acquisition
(Nov.29.2017)

Sandoz Japan President Jason Hoffe
As Sandoz gears up for the imminent launch of Japan’s first Rituxan (rituximab) biosimilar, country head Jason Hoffe has a positive outlook for its performance in Japan, with his company poised to leverage its overseas experience and its partnership with blood cancer maven Kyowa Hakko Kirin ...
(LOG IN FOR FULL STORY)